XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1

REVENUE (Tables)

3 Months Ended

Jan. 31, 2025

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

			Three Months Ended Jan 31,
			2025																								2024
			Life Sciences and Diagnostics Markets						Agilent CrossLab						Applied Markets						Total						Life Sciences and Diagnostics Markets						Agilent CrossLab						Applied Markets						Total
			(in millions)
Revenue by Region
Americas			$	312					$	261					$	96					$	669					$	283					$	253					$	94					$	630
Europe			190						188						85						463						184						185						89						458
Asia Pacific			145						247						157						549						153						248						169						570
Total			$	647					$	696					$	338					$	1,681					$	620					$	686					$	352					$	1,658

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

									Three Months Ended
									Jan 31,
															2025						2024
												(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical															$	585					$	565
Diagnostics and Clinical															240						228
Academic and Government															137						150
Chemicals and Advanced Materials															379						392
Food															168						157
Environmental and Forensics															172						166
Total															$	1,681					$	1,658
Revenue by Type
Instrumentation															$	625					$	630
Non-instrumentation and other															1,056						1,028
Total															$	1,681					$	1,658

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the changes in the balances during the three months ended January 31, 2025:

						Contract Liabilities
						(in millions)
Ending balance as of October 31, 2024						$	701
Net revenue deferred in the period						312
Revenue recognized that was included in the contract liability balance at the beginning of the period						(230)
Change in deferrals from customer cash advances, net of revenue recognized						14
Currency translation and other adjustments						(15)
Ending balance as of January 31, 2025						$	782

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration